BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1402647)

  • 1. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.
    Hammer J; Takacs B; Sinigaglia F
    J Exp Med; 1992 Oct; 176(4):1007-13. PubMed ID: 1402647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
    Hammer J; Valsasnini P; Tolba K; Bolin D; Higelin J; Takacs B; Sinigaglia F
    Cell; 1993 Jul; 74(1):197-203. PubMed ID: 8334703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.
    Davenport MP; Quinn CL; Valsasnini P; Sinigaglia F; Hill AV; Bell JI
    Immunology; 1996 Aug; 88(4):482-6. PubMed ID: 8881746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.
    Kropshofer H; Max H; Müller CA; Hesse F; Stevanovic S; Jung G; Kalbacher H
    J Exp Med; 1992 Jun; 175(6):1799-803. PubMed ID: 1375272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
    Wu S; Gorski J
    Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules.
    Max H; Halder T; Kropshofer H; Kalbus M; Müller CA; Kalbacher H
    Hum Immunol; 1993 Nov; 38(3):193-200. PubMed ID: 8106277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM.
    Raddrizzani L; Bono E; Vogt AB; Kropshofer H; Gallazzi F; Sturniolo T; Hämmerling GJ; Sinigaglia F; Hammer J
    Eur J Immunol; 1999 Feb; 29(2):660-8. PubMed ID: 10064083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer.
    Kropshofer H; Max H; Kalbacher H
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):403-7. PubMed ID: 7678456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library.
    Dybwad A; Førre O; Kjeldsen-Kragh J; Natvig JB; Sioud M
    Eur J Immunol; 1993 Dec; 23(12):3189-93. PubMed ID: 7504991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
    Natarajan SK; Stern LJ; Sadegh-Nasseri S
    J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
    Eckels DD; Geiger MJ; Sell TW; Gorski JA
    Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13.
    Hoffmann S; Willbold D
    Biochem Biophys Res Commun; 1997 Jun; 235(3):806-11. PubMed ID: 9207243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1.
    Park SJ; Sadegh-Nasseri S; Wiley DC
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11289-93. PubMed ID: 7479981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.